Search

Author/Creator Rodriguez, A

3. Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group). (18th January 2019)

Authors:
Garcia-Sanz, R; Sureda, A; de la Cruz, F; Canales, M; Gonzalez, A P; Pinana, J L; Rodriguez, A; Gutierrez, A; Domingo-Domenech, E; Sanchez-Gonzalez, B; Rodriguez, G; Lopez, J; Moreno, M; Rodriguez-Salazar, M J; Jimenez-Cabrera, S; Caballero, M D; Martinez, C
Journal:
Annals of oncology
Issue:
Volume 30:Number 4(2019)
Page Start:
612
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P3453Survival and arrhythmic mortality among ischemic and non-ischemic heart failure patients undergoing ICD-only therapy for primary prevention strategy. (28th August 2018)

Authors:
Briongos Figuero, S; Estevez, A; Sanchez, A; Perez, M L; Martinez-Ferrer, J B; Garcia, E; Vinolas, X; Arenal, A; Alzueta, J; Basterra, N; Rodriguez, A; Fernandez-Lozano, I; Munoz-Aguilera, R
Journal:
European heart journal
Issue:
Volume 39(2018)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. 17P Association of lung immune prognostic index (LIPI) with survival of first line immune checkpoint inhibitors single agent or in combination with chemotherapy in untreated advanced NSCLC patients. (15th December 2019)

Authors:
Blanc-Durand, F; Auclin, E; Planchard, D; Aix, S Ponce; Hendriks, L; Sullivan, I G; Saravia, D; Routy, B; Castro, R Lopez; Pilotto, S; Aboubakar, F; Kassouf, E; Rodriguez, A; Martin, A Amores; Bluthgen, M V; Duchemann, B; Caramella, C; Nadal, E; Besse, B; Mezquita, L
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗